Most Read This Week
- ASH 2024: Tafasitamab Tied to Improved Progression-Free Survival in Follicular Lymphoma
- ASH 2024: Early Antibiotic Deescalation Cuts Mortality in Hematologic Cancer Patients With Febrile Neutropenia
- Efficacy and Safety of Prostate Radiotherapy in Patients With De Novo Metastatic Castration-Sensitive Prostate Cancer
- De-Escalated Neoadjuvant Weekly Nab-Paclitaxel With Trastuzumab and Pertuzumab vs Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab for HER2-Positive Early Breast Cancer
- 2024 Top Story in Metastatic Breast Cancer: Epidemiology of Early vs Late Recurrence Among Women With Early-Stage ER+ Breast Cancer
Recently Updated
- Risk for Head and Neck Cancer Lower for Coffee and Tea Drinkers
- Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression
- Early-Onset CRC Incidence Rates Increased in 27 of 50 Countries, Territories
- Disparities Seen in Biennial Mammography Screening for Women in in Their 40s
- Immune and Gene-Expression Profiling in Estrogen Receptor–Low and –Negative Early Breast Cancer